FXI vs IBB
iShares China Large-Cap ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.73% for FXI.
- • FXI pays a higher dividend yield (2.14%).
Side-by-side metrics
| Metric | FXI | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.73% | 0.44% |
Dividend yield Trailing 12-month yield. | 2.14% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $4.52B | $9.09B |
YTD return | -12.01% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.47 | 0.69 |
P/E ratio | 9.22 | 24.89 |
Last price | $33.41 | $197.34 |
Inception | — | — |
Issuer | iShares | iShares |
FXI top holdings
| 0700.HK | Tencent Holdings Ltd | 9.22% |
| 00939 | China Construction Bank Corp Class H | 8.94% |
| 9988.HK | Alibaba Group Holding Ltd Ordinary Shares | 8.38% |
| 01398 | Industrial And Commercial Bank Of China Ltd Class H | 6.08% |
| 1810.HK | Xiaomi Corp Class B | 4.41% |
| 3690.HK | Meituan Class B | 4.37% |
| 9999.HK | NetEase Inc Ordinary Shares | 4.30% |
| 03988 | Bank Of China Ltd Class H | 3.95% |
| 02318 | Ping An Insurance (Group) Co. of China Ltd Class H | 3.87% |
| 01211 | BYD Co Ltd Class H | 3.13% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About FXI
FXI (iShares China Large-Cap ETF) is Largest 50 Chinese companies. Managed by iShares, the fund carries $4.5B in assets under management, an expense ratio of 0.73%, a dividend yield of 2.14%. Its largest holding is Tencent Holdings Ltd (0700.HK), which represents 9.2% of the portfolio. Real Estate is the fund's largest sector exposure at 1.0%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.